Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can training clinics to be less stigmatizing boost HIV prevention?

NCT ID NCT07464236

Knowledge-focused Sponsor: Albert Einstein College of Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether training healthcare providers to reduce stigma can increase the use of HIV and STI prevention services, like testing and preventive medications. It will involve 8 clinics in the Mississippi Delta and track changes in how often patients receive these services. The goal is to find practical ways to make care more accessible.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
PEACHES 2.0 Implementation Strategies (training and quality improvement for providers)
What this could lead to
If successful, this could show effective ways to reduce stigma and increase use of HIV and STI prevention services in clinics.
What could go wrong
This is a very small pilot study (8 clinics) with no control group, so results may not apply broadly. It focuses on implementation, not direct patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 8 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jul 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Staff participants ("Strategy Recipients" and "Strategy Recipients") * employed at one of eight Coastal Family Health Center clinics at the time of the survey * over age 18 years old Patient participants ("Patients") * accessing sexual health services at one of eight Coastal Family Health Center clinics in the last 12 months * over 18 years old Exclusion Criteria: * Staff or patients who are unable to provide informed consent (e.g., significant cognitive impairment) * Individuals currently incarcerated or in state custody * Patients whose only visits are for non-HIV, non-STI issues and who do not meet the EMR-based eligibility criteria above

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anal cancer squamous cell are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anal squamous cell carcinoma anus neoplasm chlamydia infectious disease chlamydia trachomatis infectious disease gonorrhea HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anal cancer squamous cell Chlamydia Gonorrhea HIV

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Coastal Family Health Center

    Biloxi, Mississippi, 39530, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.